References
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science, 2001
- Allen SJ, O’Donnell A, Alexander ND, et al. α+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA. 1997;94(26):14736–14741
- Denic S, Agarwal MM. Nutritional iron deficiency: an evolutionary perspective. Nutrition. 2007;23(7–8): 603–614
- Fowkes FJ, Allen SJ, Allen A, et al. Increased microerythrocyte count in homozygous α+-thalassaemia contributes to protection against severe malarial anaemia. PLoS Med. 2008;5(3):e56
- Hassan SM, Hamza N, Jaffer Al-Lawatiya F, et al. Extended molecular spectrum of β- and α-thalassemia in Oman. Hemoglobin. 2010; 34(2):127–134
- Denic S, Souid AK, Nagelkerke N, et al. Erythrocyte reference values in Emirati people with and without α+ thalassemia. BMC Blood Disord. 2011;11:1
- Denic S, Showqi S, Klein C, et al. Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Blood Disord. 2009;9:3
- Mehdi SR, Al Dahmash BA. A comparative study of hematological parameters of α and β thalassemias in a high prevalence zone: Saudi Arabia. Indian J Hum Genet. 2011;17(3):207–211
- Agouti I, Merono F, Bonello-Palot N, Badens C. Analytical evaluation of the Capillarys 2 Flex piercing for routine haemoglobinopathies diagnosis. Int J Lab Hematol. 2013;35(2):217–221
- Van Delft P, Lenters E, Bakker-Verweij M, et al. Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol. 2009;31(5):484–495
- World Health Organization. Department of Nutrition for Health and Development. Iron deficiency anaemia: assessment, prevention and control: a guide for programme managers. World Health Organization, Geneva 2001
- Khusun H, Yip R, Schultink W, Dillon DH. World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. J Nutr. 1999;129(9):1669–1674
- El-Kalla S, Baysal E. α-Thalassemia in the United Arab Emirates. Acta Haematol. 1998;100(1):49–53
- Denic S, Aden B, Nagelkerke N, Al Essa A. β-Thalassemia in Abu Dhabi: consanguinity and tribal stratification are major factors explaining the high prevalence of disease. Hemoglobin. 2013;37(4):351–358
- Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Ann Saudi Med. 2011;31(3):229–235
- Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr. 2003;49(Suppl 1):11–20
- Baysal E. α-Thalassemia syndromes in the United Arab Emirates. Hemoglobin. 2011;35(5–6):574–580
- Denic S, Agarwal MM, Al-Dabbagh B, et al. Hemoglobin A2 lowered by iron deficiency and α-thalassemia: should screening recommendation for β-thalassemia change? ISRN Hematol. 2013;2013:858294. doi: 10.1155/2013/858294
- Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Hematol. 2002;9(2):117–122
- Buchanan L, O’Connell A. A brief history of decision making. Harv Bus Rev. 2006;84(1):32–41, 132
- Denic S, Nicholls MG. A call for screening for benign neutropenia in Arab populations. Saudi Med J. 2011;32(7):738–739